Clinical Trial Shows Synthetic Cannabis Reduces Ag | Newswise

Mon, Oct 7

Clinical Trial Shows Synthetic Cannabis Reduces Agitation in Alzheimer’s Disease Synthetic THC (dronabinol) was well tolerated by patients without adverse effects often seen from current Alzheimer’s agitation medications https://t.co/mZL6jdhL1N

19796

In a study led by the Johns Hopkins University School of Medicine and Tufts University School of Medicine, researchers show that a pill form of the drug dr

Discover